Silvercrest Asset Management Group LLC Mirum Pharmaceuticals, Inc. Transaction History
Silvercrest Asset Management Group LLC
- $14.3 Billion
- Q3 2024
A detailed history of Silvercrest Asset Management Group LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Silvercrest Asset Management Group LLC holds 138,047 shares of MIRM stock, worth $5.8 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
138,047
Previous 220,490
37.39%
Holding current value
$5.8 Million
Previous $7.54 Million
28.59%
% of portfolio
0.04%
Previous 0.06%
Shares
12 transactions
Others Institutions Holding MIRM
# of Institutions
190Shares Held
54MCall Options Held
177KPut Options Held
167K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$276 Million13.79% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$188 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$145 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$136 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$129 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.55B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...